CMS is proposing to increase the end stage renal disease prospective payment base rate to $269.99 for 2024, increasing total payments to freestanding ESRD facilities by $4.42, or approximately 1.6%, compared to 2023.

For hospital-based ESRD facilities, CMS projects an increase in total payments of 2.6%.